Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Optimizing HRRm Testing and Workflow Integration in mCSPC
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Optimizing Disease Management to Improve Alopecia Areata Quality of Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    2026 Headache Medicine Fellowship - US
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Internal Medicine USA
    Advances in Migraine Management
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Real-World Evidence of SUL-DUR on Special Populations with CRAB Infection
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom
    Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Spain
    Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Efforts to Improve Quality of Migraine Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Enhancing HCP Education in Adult Vaccination against Respiratory Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland
    Migraine and Women’s Health
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement, Research Internal Medicine USA
    Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Prostate Cancer: Best Practices for Combining Targeted Therapies in mPC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Enhancing HCP Education in Maternal Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Saudi Arabia
    Diagnosis and Treatment of Cancer Cachexia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2026 Hemophilia Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi Arabia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Saudi Arabia
    Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing Equity
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology Australia
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Establishing Concordance in Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Cognition of the Significance of Vaccination and Advancement in Accessibility
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Understanding and Improving Practices Related to Post-COVID-19 Symptoms
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Optimizing Maternal Immunization Practice in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Patient Preferences for Drug Delivery: Literature Review
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Global Awards for Research in DMD-AWARD
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, India, Saudi Arabia, Singapore, Taiwan, Turkey
    Invasive Fungal Infections (Global excluding US)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Early Identification and Diagnosis of Non-Alcoholic Steatohepatitis (NASH) in At-Risk Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advances in Migraine Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Alopecia Areata (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology USA
    Advancing Health Literacy in The Republic of Ireland
    Release Date:
    Review Process: Expert Review Panel
    Education Support for the Professions Ireland
    Education to Improve Antimicrobial Resistance (AMR) Management
    Release Date:
    Partner: Japanese Society of Chemotherapy
    Review Process: Expert Review Panel
    Education Hospital Japan
    Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Promote the Streamline and Optimization of Healthcare System to Improve Regional Disparities
    Release Date:
    Partner: Japan Association for Development of Community Medicine
    Review Process: Expert Review Panel
    Quality Improvement Support for the Professions Japan
    Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Establishing Regional Medical Care Coordination System for Detailed examination of the Causes of Heart Failure
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Japan
    Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Ulcerative Colitis (UC) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, United Kingdom
    Evidence-informed treatment decisions in chronic inflammatory disorders
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Australia
    Innovative digital educational channels in Oncology for health care professionals or patients to increase local awareness
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Spain
    Individualized Menopause Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin Diseases
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Japan
    Promoting Appropriate Diagnosis and Treatment of Migraine Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
    Increasing Understanding of the Evolving Hemophilia Treatment Landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Non-Muscle Invasive Bladder Cancer Emerging Markets Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates
    Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Juvenile Idiopathic Arthritis (JIA) Patient Education
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Updates on RSV in Older Adults for Pharmacists
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    PARP-inhibitor Combination Treatments in Prostate Cancer, a Global Perspective
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Updates in RSV Prevention for Prenatal Care Workers Serving Marginalized Communities
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Acquired Aplastic Anemia: Educational programs to upskill hematologists & primary care physicians with current best practices
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Bridging the Inflammatory Dermatosis Care Divide with Teledermatology
    Release Date:
    Partner: The George Washington University
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA
    Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Support for the Professions All
    Patient Education and Support for the Management of Migraine
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)
    Release Date:
    Partner: Bristol-Myers Squibb
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital Malawi, Rwanda, Senegal
    Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA